Varaico: Literature-Extracted Genetic Variants

Gene:SYNGAP1
Variant:p.V1195fs
Back to variants list

SYNGAP1

NM_006772.3:p.V1195fs

Associated Papers

Sleep complaints in individuals with SYNGAP1-associated syndrome.

Mosini AC et al.

Sleep Medicine, 2025

Novel De Novo Intronic Variant of SYNGAP1 Associated With the Neurodevelopmental Disorders.

Xie W et al.

Molecular Genetics & Genomic Medicine, 2025

Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism.

Wiltrout K et al.

Epilepsia, 2024

Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites.

Zhang P et al.

Proceedings of the National Academy of Sciences of the United States of America, 2023

37931111 (PubMed )
Supplement: pnas.2314225120.sd01.xlsx › Dataset_S1._patho_AG-gain_var

Candidate Genes for Eyelid Myoclonia with Absences, Review of the Literature.

Mayo S et al.

International Journal of Molecular Sciences, 2021

SYNGAP1-DEE: A visual sensitive epilepsy.

Lo Barco T et al.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology, 2021

Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.

Jimenez-Gomez A et al.

Journal of Neurodevelopmental Disorders, 2019

31395010 (PubMed )
Supplement: 11689_2019_9276_MOESM1_ESM.xlsx › Sheet1

Clinical Transcriptome Sequencing Confirms Activation of a Cryptic Splice Site in Suspected SYNGAP1-Related Disorder.

Brimble E et al.

Molecular Syndromology, 2019

Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.

Okazaki T et al.

Epileptic Disorders : International Epilepsy Journal With Videotape, 2017

Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.

Redin C et al.

Journal of Medical Genetics, 2014

Roadmap to advance therapeutics for SYNGAP1-related disorder: a patient organization perspective from SynGAP Research Fund.

Graglia JM et al.

Therapeutic Advances in Rare Disease, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."